U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239765) titled 'A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD' on Nov. 16.
Brief Summary: Amphotericin B Cholesteryl Sulfate Complex (ABCD) is a generic drug of amphotericin B colloidal dispersion. This study aimed to explore the safety and efficacy of ABCD in patients with invasive mold disease.
Study Start Date: July 09, 2021
Study Type: INTERVENTIONAL
Condition:
Invasive Mold Disease
Intervention:
DRUG: ABCD
intravenous infusion
Recruitment Status: COMPLETED
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....